Arca
Skip to content
Tools
Tools

-dopa

Dopamine-like drugs used in Parkinson's disease or to lower prolactin.

  • Drugs ending in -dopa: 14
  • Approved somewhere: 5
  • With a US drug page: 5

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-dopa
Class
Dopamine-like drugs used in Parkinson's disease or to lower prolactin
Sub-stems
-opamine
Most common targets
DRD3 (2), DDC (2), ADRB1 (2), Adrenergic receptor (1), Adrenergic receptor alpha-2 (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -dopa or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
DroxidopaApprovedAdrenergic receptorAdrenergic receptor agonist
LevodopaApprovedDRD3Dopamine D3 receptor agonist
MethyldopaApprovedAdrenergic receptor alpha-2Adrenergic receptor alpha-2 agonist
Methyldopa (racemic)Phase 1——
Carbidopa anhydrousApprovedDDCDOPA decarboxylase inhibitor
FluorodopaPhase 3—Diagnostic agent
FoslevodopaPhase 3ADRB1Beta-1 adrenergic receptor agonist
MelevodopaPhase 2——
FoscarbidopaPhase 1DDCDOPA decarboxylase inhibitor
Etilevodopa—DRD3Dopamine D3 receptor agonist
DopamineApprovedADRB1Beta-1 adrenergic receptor agonist
IbopaminePhase 2——
OctopaminePhase 2——
TolpropaminePhase 2——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.